GlaxoSmithKline Pharmaceuticals Market Cap ($4.97B USD)
GlaxoSmithKline Pharmaceuticals Market Cap ($4.97B USD). As of Nov. 19, 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) market capitalisation is ₹44692.70 Cr ($4.97B), with 16.47 Cr shares outstanding at a current price of ₹2713.40 on NSE, ranking 216 out of 5368 companies by market cap in our screener. GlaxoSmithKline Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. Review GLAXO earnings valuation to evaluate earnings-based valuation against sector peers.
Market Cap History of GlaxoSmithKline Pharmaceuticals (Last 10 Years)
GLAXO market capitalisation from year-end NSE closing prices over the last 10 years.
End of Year Market Cap History — GlaxoSmithKline Pharmaceuticals
GLAXO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see GlaxoSmithKline Pharmaceutical stock price NSE.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹44692.70 Cr
$4.97B USD
|
₹2713.40 | NSE | +9.69% |
| 2025 |
₹40742.93 Cr
$4.53B USD
|
₹2473.60 | NSE | +9.85% |
| 2024 |
₹37090.46 Cr
$4.12B USD
|
₹2251.85 | NSE | +18.63% |
| 2023 |
₹31264.63 Cr
$3.47B USD
|
₹1898.15 | NSE | +43.94% |
| 2022 |
₹21721.27 Cr
$2.41B USD
|
₹1318.75 | NSE | -24.93% |
| 2021 |
₹28933.97 Cr
$3.21B USD
|
₹1756.65 | NSE | +8.17% |
| 2020 |
₹26748.25 Cr
$2.97B USD
|
₹1623.95 | NSE | +0.85% |
| 2019 |
₹26523.42 Cr
$2.95B USD
|
₹1610.30 | NSE | +6.27% |
| 2018 |
₹24959.49 Cr
$2.77B USD
|
₹1515.35 | NSE | +21.75% |
| 2017 |
₹20500.76 Cr
$2.28B USD
|
₹1244.65 | NSE | -8.81% |
| 2016 |
₹22481.41 Cr
$2.50B USD
|
₹1364.90 | NSE | -17.63% |
| 2015 |
₹27293.12 Cr
$3.03B USD
|
₹1657.03 | NSE | +3.61% |
| 2014 |
₹26341.09 Cr
$2.93B USD
|
₹1599.23 | NSE | +6.68% |
| 2013 |
₹24692.66 Cr
$2.74B USD
|
₹1499.15 | NSE | +38.29% |
| 2012 |
₹17855.17 Cr
$1.98B USD
|
₹1084.03 | NSE | +11.46% |
| 2011 |
₹16019.47 Cr
$1.78B USD
|
₹972.58 | NSE | -16.78% |
| 2010 |
₹19250.61 Cr
$2.14B USD
|
₹1168.75 | NSE | +45.01% |
| 2009 |
₹13275.38 Cr
$1.48B USD
|
₹805.98 | NSE | +40.09% |
| 2008 |
₹9476.32 Cr
$1.05B USD
|
₹575.33 | NSE | +12.02% |
| 2007 |
₹8459.56 Cr
$939.95M USD
|
₹513.60 | NSE | -11.67% |
| 2006 |
₹9577.62 Cr
$1.06B USD
|
₹581.48 | NSE | +3.67% |
| 2005 |
₹9238.31 Cr
$1.03B USD
|
₹560.88 | NSE | +45.67% |
| 2004 |
₹6341.87 Cr
$704.65M USD
|
₹385.03 | NSE | +34.30% |
| 2003 |
₹4722.27 Cr
$524.70M USD
|
₹286.70 | NSE | - |